quinoxalines has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, AH; Denby, L; McBride, M; Ramdas, V | 1 |
| Kettritz, R; Luft, FC; Peripelittchenko, L; Rademann, J; Rolle, S; Schneider, W; Schreiber, A | 1 |
2 other study(ies) available for quinoxalines and Bright Disease
| Article | Year |
|---|---|
Canonical transforming growth factor-β signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29.
Topics: Animals; Cell Line; Disintegrins; Fibrosis; Gene Expression Regulation, Enzymologic; Glomerulonephritis; Imidazoles; Male; Mice; MicroRNAs; Quinoxalines; Rats; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta | 2013 |
Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis.
Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Cell Adhesion; Cell Degranulation; Cell Movement; Cells, Cultured; Class Ib Phosphatidylinositol 3-Kinase; Female; Glomerulonephritis; Humans; Isoenzymes; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinoxalines; Reactive Oxygen Species; Thiazolidinediones | 2010 |